Genomed Spólka Akcyjna reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was PLN 4.8 million compared to PLN 4.6 million a year ago. Net loss was PLN 0.307999 million compared to PLN 0.559355 million a year ago.
For the six months, revenue was PLN 10.58 million compared to PLN 9.64 million a year ago. Net loss was PLN 0.452948 million compared to PLN 0.390755 million a year ago.